MicroCME 2023

The College is pleased to offer these 15 to 30 minute modules that will give you CME designed to fit your busy schedule! The MicroCME project helps close gaps in busy clinicians’ knowledge and practice by providing a curated selection of the “best of the best”, most relevant and compelling individual presentations from the ACAAI annual meeting. These curated presentations help clinicians to stay up to date with the latest research and strategies in the field.

Continue to visit this page as NEW modules will be added as they are developed. Each module is available for up to 0.5 AMA PRA Category 1 creditsTM. Participants earn credit by completing individual courses and completing the test.

Topics:

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Practicing allergists
Allied health professionals
Primary Care Providers
Fellows-in-Training

Learning Objectives

By participating in these courses, learners should be able to:

  • Evaluate the latest research in the field of allergy/immunology relevant to practice.
  • Utilize tools and techniques to implement the latest therapy recommendations.
  • Employ tools they need to monitor their practice and assess the implementation of therapy recommendations.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines an “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Examples of such organizations include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships have been mitigated.

Course summary
Course opens: 
04/01/2023
Course expires: 
12/31/2024
Rating: 
0

Mary Beth Hudelson, MD, FACAAI, planner/reviewer - No relevant financial relationships
Joel Klein, MD, FACAAI, planner- No relevant financial relationships
Tammy Peng, MD, planner- No relevant financial relationships
Desha Jordan, MD, planner- No relevant financial relationships
Karen Anstey, MD, planner- Speaker (Sanofi); Contracted research (GlaxoSmithKline) 
Evelyn Lomasney, MD, planner- No relevant financial relationships
Deepa Patadia, MD, planner - No relevant financial relationships
Brianne Nicole Navetta-Modrov, MD, planner- No relevant financial relationships
Hyun Jun (Robert) Park, MD, planner- No relevant financial relationships

Please login or create an account to take this course.